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 Mortality trends in South Africa: progress in the shadow of 
HIV/AIDS and apartheid
In The Lancet Global Health, Victoria Pillay-van Wyk 
and colleagues1 report a large-scale analysis of more 
than 8 million deaths that occurred in South Africa 
over a 16-year period (1997–2012). The study provides 
important subnational information on mortality by 
province and by the diﬀ erent communities in South 
Africa—a feature that is a major improvement on the 
previous studies of the burden of disease in South Africa2 
and the Global Burden of Disease study3—thus making 
this report more useful to policy makers and planners at 
national and provincial levels of the country. HIV/AIDS 
remains the leading cause of death (accounting for 
50% of deaths), although deaths from the disease have 
decreased substantially across all provinces over the past 
10 years. Although deaths related to non-communicable 
disease and injury have also stabilised, mortality from 
type 1 conditions that include infectious diseases such 
as lower respiratory tract infection, septicaemia, or 
neonatal causes have not.
Pillay-van Wyk and colleagues1 report an increase 
in age-standardised death rates from diabetes and 
renal disease from 1997 to 2012,2 substantial death 
rates from non-communicable diseases in individuals 
aged 40–44 years (earlier onset than in high-income 
settings),3 and race-related inequity in distribution of 
causes of death, underlining the persisting eﬀ ect of the 
apartheid system.4 
Evidence of disease–disease and drug–disease 
interactions between HIV, tuberculosis, and non-
communicable diseases is increasing.5 There has also 
been recent research into the changing epidemiology 
of population health towards co-existing chronic 
infections and non-communicable diseases.6 Pillay-
van Wyk and colleagues cite the importance of this 
epidemiological interaction between communicable 
and non-communicable diseases in recent studies6 
into the cardiovascular disease risk proﬁ le associated 
with antiretroviral therapy.1 Known interactions also 
exist between antiretroviral therapy and diabetes, and 
evidence of interaction between HIV and the most 
common non-communicable diseases, including 
chronic respiratory disease, is increasing.7 In response 
to these changing epidemiological patterns, the South 
African National Strategic Plan for non-communicable 
diseases seeks to address chronic infectious disease 
comorbidity through an Integrated Chronic Disease 
Management tool in order for health-care delivery, 
and more broadly health systems, to adapt to this 
population health need.8 This strategy is essential to 
prevent a reversal of the positive eﬀ ects of antiretroviral 
therapy on HIV outcomes that have been achieved in 
South Africa. The diﬀ erential states of epidemiological 
transition in diﬀ erent population groups shown in this 
study, and the importance of the diﬀ erential exposures 
to the social determinants of health, is highlighted with 
the association between health outcomes and gross 
domestic product per head. 
The importance of social determinants on population 
health is widely known. Beyond this recognition, 
key questions that still need to be addressed include 
research into how to best address social determinants 
through intersectoral collaboration. Pillay-van Wyk 
and colleagues identify this approach as necessary 
to the reduction of the heavy burden of violence and 
injury. However, this approach is also important for 
other causes of death, particularly non-communicable 
diseases, tuberculosis, and the type 1 conditions. At the 
ﬁ rst UN multistakeholder forum on science, technology, 
and innovation for the sustainable development 
goals (SDGs), the need for new partnerships and 
collaborations was underscored as necessary to achieve 
these goals.9 
HIV infection still accounts for the greatest proportion 
of deaths, largely driven by the inequitable exposures 
that aﬀ ect health and the risk of acquisition of HIV faced 
by black Africans who constitute most of the South 
African population. These data are therefore important 
for agenda setting to address the SDGs. To achieve the 
population health targets, we will need to address not 
only the targets related to the health goal (goal 3) but 
also other health-related targets across other SDGs, 
including goals on food security (goal 2), water and 
sanitation (goal 6), and healthier cities (goal 11). This 
will necessitate thorough evidence-based assessment 
of the interactions between the SDGs in diﬀ erent 
contexts.10 This study shows that the measurement 
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and monitoring of mortality trends can increasingly be 
done in low-income and middle-income settings and 
highlights the importance of strengthening surveillance 
systems to assess the eﬀ ect of intersectoral actions to 
improve population health.1 
South Africa seems to have turned the tide against 
rapidly rising mortality caused by HIV/AIDS through 
the application of evidence-based interventions 
in the health system and beyond. Future progress 
will depend on addressing the triple challenges of 
implementing interventions to end HIV/AIDS by 2030, 
providing universal access to quality health care for 
all, and eradicating racial inequality, unemployment, 
and poverty.4 These extraordinary challenges should 
be matched by the resolute application of eﬀ ective 
interventions by all sectors of society to achieve the 
SDGs by 2030.
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